American Association for Cancer Research
Browse
00085472can182616-sup-207438_3_supp_5359115_pnjjdn.docx (16.89 kB)

Supplementary Methods from Collagen Remodeling in the Hypoxic Tumor-Mesothelial Niche Promotes Ovarian Cancer Metastasis

Download (16.89 kB)
journal contribution
posted on 2023-03-31, 03:20 authored by Suchitra Natarajan, Kaitlyn M. Foreman, Michaela I. Soriano, Ninna S. Rossen, Hussein Shehade, Daniel R. Fregoso, Joshua T. Eggold, Venkatesh Krishnan, Oliver Dorigo, Adam J. Krieg, Sarah C. Heilshorn, Subarna Sinha, Katherine C. Fuh, Erinn B. Rankin

Document contains detailed procedures of materials and methods.

Funding

Defense for Health Affairs

History

ARTICLE ABSTRACT

Peritoneal metastases are the leading cause of morbidity and mortality in high-grade serous ovarian cancer (HGSOC). Accumulating evidence suggests that mesothelial cells are an important component of the metastatic microenvironment in HGSOC. However, the mechanisms by which mesothelial cells promote metastasis are unclear. Here, we report that the HGSOC tumor-mesothelial niche was hypoxic, and hypoxic signaling enhanced collagen I deposition by mesothelial cells. Specifically, hypoxic signaling increased expression of lysyl oxidase (LOX) in mesothelial and ovarian cancer cells to promote collagen crosslinking and tumor cell invasion. The mesothelial niche was enriched with fibrillar collagen in human and murine omental metastases. Pharmacologic inhibition of LOX reduced tumor burden and collagen remodeling in murine omental metastases. These findings highlight an important role for hypoxia and mesothelial cells in the modification of the extracellular matrix and tumor invasion in HGSOC. This study identifies HIF/LOX signaling as a potential therapeutic target to inhibit collagen remodeling and tumor progression in HGSOC.

Usage metrics

    Cancer Research

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC